Efficacy and safety of rechallenge with [(177)Lu]Lu-PSMA-I&T radioligand therapy in metastatic castration resistant prostate cancer
转移性去势抵抗性前列腺癌再次使用[(177)Lu]Lu-PSMA-I&T放射性配体疗法的疗效和安全性
期刊:European Journal of Nuclear Medicine and Molecular Imaging
影响因子:7.6
doi:10.1007/s00259-024-06905-5
Santo, Giulia; Di Santo, Gianpaolo; Sviridenko, Anna; Bayerschmidt, Steffen; Wirth, Lukas; Scherbauer, Fabian; Lehmann, Peter; von Guggenberg, Elisabeth; Decristoforo, Clemens; Heidegger-Pircher, Isabel; Bektic, Jasmin; Virgolini, Irene
